Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 695-988-9 | CAS number: 100556-82-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Mutagenic behaviour of Reactive Black 5 in its bis-ester form was assessed in bacteria in vitro. In a GLP compliant study according to OECD 471 no mutagenic effects have been noted in the plate incorporation tests and in the preincubation tests conducted both in presence and absence of an exogenous metabolic activation system. In addition, also data on one of the metabolic breakdown products of Reactive Black 5 are available showing also no mutagenic effects in the bacterial test system.
To support these initial findings, mutagenic and clastogenic effects have been investigated in vivo. A GLP compliant study according to OECD 475 investigated effects of the test substance on chromosomal level after single treatment of 5000 mg/kg bw. The test item was administered once orally by gavage in a single dose of 5000 mg/kg bodyweight to male and female Chinese hamsters. This dose had been shown in a preliminary study to be the maximum tolerated dose. As a result no increase of chromosomal aberrations have been noted compared to control. Therefore the test was judged negative (non-clastogenic) in this in vivo test system.
To test mutagenic behaviour of the test item in vivo, the test substance was administered once by gavage as single doses of 0 (vehicle control), 2000 and 10000 mg/kg bodyweight to male and female NMRI mice (5 mice per sex and killing time point). 10000 mg/kg bw had been shown in a preliminary study to be the maximum feasible dose. A positive control group received Endoxan at an oral dose of 50 mg/kg body weight. Animals were killed 12, 24, or 48 hours after treatment. The bone marrow obtained from femora of the animals was prepared, placed on microscopic slides and stained. 1000 poly- and 1000 normochromatic erythrocytes were screened for micronuclei. In addition, the ratio of polychromatic to normochromatic erythrocytes was determined. Under the conditions tested, the test item caused no significant increase in the number of cells with micronuclei in the bone marrow cells of treated animals as compared with the control group. The results indicate that, under the conditions of the test, the test item is not mutagenic in the in vivo micronucleus test.
Based on these results in vivo, the test substance is considered to be not mutagenic and not clastogenic in vivo.
Short description of key information:
The test substance showed negative results in the Salmonella typhimurium reverse mutation assay (OECD 471) in vitro and in OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test) and in OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test) studies in vivo. The substance is therefore considered to be non-mutagenic and non clastogenic.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on the available genotoxicity studies, the test substance does not need to be classified for genotoxicity according to Directive 67/548/EEC and according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.